...
首页> 外文期刊>Clinical and experimental ophthalmology >Dacryocystorhinostomy for epiphora in the presence of a patent lacrimal system.
【24h】

Dacryocystorhinostomy for epiphora in the presence of a patent lacrimal system.

机译:泪囊鼻腔吻合术用于泪溢的泪腺系统。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

PURPOSE: To evaluate the success rate of dacryocystorhinostomy (DCR) for epiphora in patients with a clinically patent lacrmal drainage system. METHODS: A series of 51 patients, 12 men and 39 women, who underwent DCR surgery for epiphora with a clinically patent lacrimal drainage system in the background of normal eyelid examination, were evaluated. All patients underwent fluorescein dye disappearance testing and Jones 1 and 2 testing with dacryocystograms in borderline cases. A standard DCR was performed with bicanalicular silicone tubing inserted in all cases. The average time for the removal of the silicone tubes was 9.6 weeks. RESULTS: In 48 cases (94%) there was improvement in symptoms with minimal or no significant epiphora postoperatively. CONCLUSIONS: Epiphora with a patent lacrimal drainage system obstruction can be successfully treated by DCR based on fluorescein dye disappearance tests and Jones 1 and 2 tests, with dacryocystography in borderline cases.
机译:目的:评估泪囊鼻腔吻合术(DCR)在临床上有专利的泪液引流系统患者中的成功率。方法:对51例患者(12例男性和39例女性)在正常眼睑检查的背景下接受DCR手术以治疗泪溢,并使用临床上有专利的泪道引流系统进行了评估。所有患者在临界情况下都接受了荧光素染料的消失测试以及Jones 1和2的泪囊造影检查。在所有情况下,均在插入双管硅胶管的情况下进行标准DCR。取出硅胶管的平均时间为9.6周。结果:48例(94%)患者术后症状改善,癫痫发作最少或无明显症状。结论:基于荧光素染料消失试验和Jones 1和2试验,并有泪囊造影的临界病例,DCR可以成功治疗泪溢带阻塞的泪溢。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号